Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma
- PMID: 28603323
- PMCID: PMC5460661
- DOI: 10.1080/01621459.2016.1191499
Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma
Abstract
We showcase a novel analytic strategy to identify sub-types of cancer that possess distinctive causal factors, i.e. sub-types that are "etiologically" distinct. The method involves the integrated analysis of two types of study design: an incident series of cases with double primary cancers with detailed information on tumor characteristics that can be used to define the sub-types; a case-series of incident cases with information on known risk factors that can be used to investigate the specific risk factors that distinguish the sub-types. The methods are applied to a rich melanoma dataset with detailed information on pathologic tumor factors, and comprehensive information on known genetic and environmental risk factors for melanoma. Identification of the optimal sub-typing solution is accomplished using a novel clustering analysis that seeks to maximize a measure that characterizes the distinctiveness of the distributions of risk factors across the sub-types and that is a function of the correlations of tumor factors in the case-specific tumor pairs. This analysis is challenged by the presence of extensive missing data. If successful, studies of this nature offer the opportunity for efficient study design to identify unknown risk factors whose effects are concentrated in defined sub-types.
Keywords: case-control study; etiologic heterogeneity; k-means clustering; logistic regression; multiple imputation.
Figures
Similar articles
-
Genomic investigation of etiologic heterogeneity: methodologic challenges.BMC Med Res Methodol. 2014 Dec 22;14:138. doi: 10.1186/1471-2288-14-138. BMC Med Res Methodol. 2014. PMID: 25532962 Free PMC article.
-
Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer.Cancer Med. 2015 Sep;4(9):1432-9. doi: 10.1002/cam4.456. Epub 2015 May 13. Cancer Med. 2015. PMID: 25974664 Free PMC article.
-
A conceptual and methodological framework for investigating etiologic heterogeneity.Stat Med. 2013 Dec 20;32(29):5039-52. doi: 10.1002/sim.5902. Epub 2013 Jul 16. Stat Med. 2013. PMID: 23857589 Free PMC article.
-
Defining etiologic heterogeneity in breast cancer using genetic biomarkers.Prog Clin Biol Res. 1997;396:53-61. Prog Clin Biol Res. 1997. PMID: 9108589 Review.
-
Melanoma Epidemiology and Prevention.Cancer Treat Res. 2016;167:17-49. doi: 10.1007/978-3-319-22539-5_2. Cancer Treat Res. 2016. PMID: 26601858 Review.
Cited by
-
Family Study Designs Informed by Tumor Heterogeneity and Multi-Cancer Pleiotropies: The Power of the Utah Population Database.Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):807-815. doi: 10.1158/1055-9965.EPI-19-0912. Epub 2020 Feb 25. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32098891 Free PMC article.
-
Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer Study.Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1784-1791. doi: 10.1158/1055-9965.EPI-19-0365. Epub 2019 Aug 8. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 31395590 Free PMC article.
-
Validity of a method for identifying disease subtypes that are etiologically heterogeneous.Stat Methods Med Res. 2021 Sep;30(9):2045-2056. doi: 10.1177/09622802211032704. Epub 2021 Jul 28. Stat Methods Med Res. 2021. PMID: 34319833 Free PMC article.
-
Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity.Br J Dermatol. 2021 Jun;184(6):1085-1093. doi: 10.1111/bjd.19705. Epub 2021 Feb 18. Br J Dermatol. 2021. PMID: 33270213 Free PMC article.
-
Melanocyte lineage dynamics in development, growth and disease.Development. 2024 Aug 1;151(15):dev201266. doi: 10.1242/dev.201266. Epub 2024 Aug 2. Development. 2024. PMID: 39092608 Free PMC article. Review.
References
-
- Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiology. Biomarkers and Prevention. 2004;13:1558–1568. - PubMed
-
- Bauer J, Büttner P, Murali R, Okamoto I, Kolaitis NA, Landi MT, Scolyer RA, Bastian BC. BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Pigment Cell and Melanoma Research. 2011;24(2):345–51. - PMC - PubMed
-
- Begg CB, Gray RJ. Calculation of polychotomous logistic regression parameters using individualized regressions. Biometrika 1984. 1984;71:11–18.
-
- Begg CB, Zhang ZF. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiology, Biomarkers and Prevention. 1994;3:173–175. - PubMed
-
- Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Berwick M. A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. International Journal of Epidemiology. 2006;35:756–764. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources